US FDA's New Paragraph IV Data Further Illustrates Generic Competition Problems

 
• By Derrick Gingery
  
Generics
The US FDA is releasing more patent-related information for generic drug sponsors. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics